INOZYME PHARMA, INC. Diluted Shares Outstanding (Weighted Average)
INOZYME PHARMA, INC. reported Diluted Shares Outstanding (Weighted Average) of 64.28 million shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-05-14
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 64.28M shares, a 4.06% increase year-over-year.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 64.24M shares, a 3.83% increase year-over-year.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 63.28M shares, a 11.48% increase year-over-year.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2024-06-30 was 61.94M shares, a 38.08% increase year-over-year.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 62.81M shares, a 21.17% increase from fiscal 2023.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 51.84M shares, a 37.27% increase from fiscal 2022.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 37.76M shares, a 60.30% increase from fiscal 2021.
- INOZYME PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 23.56M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2025-03-31 | 64.28M shares 10-Q · filed 2025-05-14 | 64.26M shares derived: average of 2 quarters · filed 2025-05-14 | 63.93M shares derived: average of 3 quarters · filed 2025-05-14 | 63.44M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | 64.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 63.76M shares derived: average of 2 quarters · filed 2025-03-10 | 63.15M shares derived: average of 3 quarters · filed 2025-03-10 | 62.81M shares 10-K · filed 2025-03-10 |
| 2024-09-30 | 63.28M shares 10-Q · filed 2024-11-05 | 62.61M shares derived: average of 2 quarters · filed 2024-11-05 | 62.33M shares 10-Q · filed 2024-11-05 | 62.22M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | 61.94M shares 10-Q · filed 2024-08-06 | 61.86M shares 10-Q · filed 2024-08-06 | 61.86M shares derived: average of 3 quarters · filed 2025-05-14 | 60.59M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | 61.77M shares 10-Q · filed 2025-05-14 | 61.82M shares derived: average of 2 quarters · filed 2025-05-14 | 60.13M shares derived: average of 3 quarters · filed 2025-05-14 | 56.32M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 61.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | 59.32M shares derived: average of 2 quarters · filed 2025-03-10 | 54.50M shares derived: average of 3 quarters · filed 2025-03-10 | 51.84M shares 10-K · filed 2025-03-10 |
| 2023-09-30 | 56.76M shares 10-Q · filed 2024-11-05 | 50.81M shares derived: average of 2 quarters · filed 2024-11-05 | 48.49M shares 10-Q · filed 2024-11-05 | 47.28M shares derived: average of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | 44.86M shares 10-Q · filed 2024-08-06 | 44.29M shares 10-Q · filed 2024-08-06 | 44.12M shares derived: average of 3 quarters · filed 2024-08-06 | 44.01M shares derived: average of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | 43.72M shares 10-Q · filed 2024-05-07 | 43.75M shares derived: average of 2 quarters · filed 2024-05-07 | 43.72M shares derived: average of 3 quarters · filed 2024-05-07 | 42.72M shares derived: average of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | 43.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 43.72M shares derived: average of 2 quarters · filed 2024-03-12 | 42.38M shares derived: average of 3 quarters · filed 2024-03-12 | 37.76M shares 10-K · filed 2024-03-12 |
| 2022-09-30 | 43.66M shares 10-Q · filed 2023-11-07 | 41.68M shares derived: average of 2 quarters · filed 2023-11-07 | 35.76M shares 10-Q · filed 2023-11-07 | 32.68M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 39.70M shares 10-Q · filed 2023-08-08 | 31.74M shares 10-Q · filed 2023-08-08 | 29.02M shares derived: average of 3 quarters · filed 2023-08-08 | 27.68M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 23.69M shares 10-Q · filed 2023-05-09 | 23.68M shares derived: average of 2 quarters · filed 2023-05-09 | 23.67M shares derived: average of 3 quarters · filed 2023-05-09 | 23.62M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 23.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 23.66M shares derived: average of 2 quarters · filed 2023-03-22 | 23.60M shares derived: average of 3 quarters · filed 2023-03-22 | 23.56M shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 23.64M shares 10-Q · filed 2022-11-10 | 23.57M shares derived: average of 2 quarters · filed 2022-11-10 | 23.52M shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 23.49M shares 10-Q · filed 2022-08-15 | 23.46M shares 10-Q · filed 2022-08-15 |